GPCR Flashcards
GPCR structure
- 7 TM domain receptor protein
- 800 human GPCRs
- 33% of small molecule drugs are GPCR targeting
- activates trimeric G protein via GTP exchangve
- leads to activation of further enzymes
GPCR signals
- photons (vision)
- exogenous small molecules (smell, taste)
- neurotransmitters (serotonin)
- peptide/small molecule hormones
- proteins
Pharmacological terms
- all GPCRs have small level of basal/constitutive activity
- full agonist: native ligand gives 100% full activity
- partial agonist: close to full activity
- neutral agonist: suppress activity back to basal levels
- inverse agonist: inhibit to 0% (even basal levels inhibited)
B2-adrenergic receptor
- class A GPCR rhodopsin-like
- two conformations (active vs inactive)
GPCR Families
Class A: normal GPCR structure
Class B: larger extracellular domain/peptide hormones
Class C: orthosteric binding site/allosteric binding site/ intracellular dimerisation of receptors
Class D: frizzled and smoothened receptors/larger extracellular domains
G Protein Activation
- heterotrimeric protein activated by ligand bound GPCR
(1) Agonist binding leads to a conformational change in the GPCR, which stimulates GDP/GTP exchange in the G protein.
(2) Active, GTP-bound, G protein dissociates into α subunit and βγ dimer (both are membrane-bound due to lipid modifications).
(3) The α subunit and βγ dimer regulate effector proteins (AC, adenylyl cyclase).
- AC converts ATP to cAMP as secondary messenger
(4) GTP hydrolysis deactivates the α subunit, which reassembles with the βγ dimer.
- By dimer can inactivate effectors (like Ca ion transporter)
Models of GPCR activation
- memorise models *
Simple binding and activation: - equilibrium of inactive/active form relating to the protein a-helical change
Simple ternary complex model:
- describes G protein association
Extended ternary complex model:
- describes the constitutive activity levels (can have signalling without input)
- agonist drives equilibrium to a state which is more effective in coupling (increased activity)
Adenylyl Cyclase Structure
- G alpha protein effector
- membrane spanning protein with 12 TM helices
- two TM domains with both termini inside cell
- two intracellular loops (C1a/C2a) with enzymatic activity
Adenylyl Cyclase Activity
- Ga unit binds to AC protein
- removes inorganic diphosphate from ATP to form cyclic AMP
- cAMP phosphodiesterase hydrolyses cAMP to AMP
Cyclic AMP-dependent protein kinase A
- Mediate cAMP effects/Activated by cAMP
- Kinase phosphorylates specific serine/threonines on target proteins to regulate activity
- Inactivate state: PKA has two catalytic units and two regulatory units. cAMP binding to regulatory units alters conformation causing dissociation
- regulatory unit penetrates active site cleft to block activity
- Released catalytic units activated to phosphorylate target proteins
- In unstimulated cells, a phosphodiesterase keeps cAMP conc. Low to inactivate PKA
- PKA phosphorylates a target protein that is a phosphodiesterase to lower the cAMP concentration and make a pulse of PKA activity
Somatostatin
- inhibitory hormone
- in digestive system: decreases gastric emptying and release of pancreatic hormones
- in nervous system: decreases pituitary hormone release
- expression induced by cAMP via PKA dependent pathway
- slow response mediated by PKA: transcription factors
- cAMP activates the gene that encodes this hormone. The regulatory region of the somatostatin gene contains a short cis-regulatory sequence, called the cyclic AMP response element (CRE), which is also found in the regulatory region of many other genes activated by cAMP.
- A specific transcription regulator called CRE-binding (CREB) protein recognizes this sequence. When PKA is activated by cAMP, it phosphorylates CREB on a single serine; phosphorylated CREB then recruits a transcriptional coactivator called CREB-binding protein (CBP), which stimulates the transcription of the target genes
- Thus, CREB can transform a short cAMP signal into a long-term change in a cell, a process that, in the brain, is thought to play an important part in some forms of learning and memory.
Fight or Flight Response
- fast response mediated by PKA: ion channel
- B-adrenergic receptor activated by adrenaline
- cAMP production increases to activate PKA
- phosphorylates B0subunit to release from the Ca ion channel
- releases inhibitory effect to allow Ca signalling
Phospholipase C-B
- Ga protein effector
- CT domain in membrane linked to PLC-B in intracellular leaflet
- GPCRs can use G proteins to activate the membrane bound enzyme phospholipase C-B
- PLC-B has X/Y linker blocking active site when inactivated
- PLC-B in the active state has X/Y linker moved out (allosteric activation)
Phospholipase C-B activity
- Phospholipase acts on a phosphorylated ionositol phosphoplipid (phosphoinositide) called PIP2.
- Receptors that activate this inositol phospholipid signaling pathway mainly do so via a G protein called Gq, which activates phospholipase C-β in much the same way that Gs activates adenylyl cyclase. The activated phospholipase then cleaves the PI(4,5)P2 to generate two products: inositol 1,4,5-trisphosphate (IP3) and diacylglycerol. At this step, the signaling pathway splits into two branches.
1) IP3 binds to IP3 gated calcium channels in the ER to release ions. Increase in cytosolic calcium propagates the signal by influencing activity of calcium sensitive proteins.
2) Diaglycerol is in the membrane where it activates protein kinase C (calcium dependent). Initial rise in Ca alters PKC to translocate to the cytoplasmic face of the membrane where it is activated. - ER membrane contains another type of Ca channel opening in response to rising Ca levels to amplify the signal. Calcium induced calcium release results in positive feedback loops. The receptors are inhibited after some delay by the high Ca concentrations lowering the signal.
PIP2 hydrolysis
- learn structure*
- PLC-B hydrolyses phosphatidylinositol 4,5-bisphosphate into diacylglycerol and inositol 1,4,5-trisphosphate